Praxis Precision Medicines Inc (PRAX)
54.54
+0.38
(+0.70%)
USD |
NASDAQ |
May 03, 16:00
54.84
+0.30
(+0.55%)
Pre-Market: 20:00
Praxis Precision Medicines Market Cap: 722.02M for May 3, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 03, 2024 | 722.02M |
| May 02, 2024 | 716.99M |
| May 01, 2024 | 730.22M |
| April 30, 2024 | 726.39M |
| April 29, 2024 | 752.73M |
| April 26, 2024 | 725.46M |
| April 25, 2024 | 700.04M |
| April 24, 2024 | 677.01M |
| April 23, 2024 | 646.56M |
| April 22, 2024 | 632.53M |
| April 19, 2024 | 620.74M |
| April 18, 2024 | 616.77M |
| April 17, 2024 | 672.24M |
| April 16, 2024 | 693.82M |
| April 15, 2024 | 706.79M |
| April 12, 2024 | 730.22M |
| April 11, 2024 | 712.49M |
| April 10, 2024 | 669.46M |
| April 09, 2024 | 697.79M |
| April 08, 2024 | 710.76M |
| April 05, 2024 | 665.36M |
| April 04, 2024 | 671.71M |
| April 03, 2024 | 701.63M |
| April 02, 2024 | 735.65M |
| April 01, 2024 | 775.76M |
| Date | Value |
|---|---|
| March 28, 2024 | 807.80M |
| March 27, 2024 | 783.71M |
| March 26, 2024 | 823.16M |
| March 25, 2024 | 668.53M |
| March 22, 2024 | 713.15M |
| March 21, 2024 | 693.82M |
| March 20, 2024 | 739.76M |
| March 19, 2024 | 711.56M |
| March 18, 2024 | 722.41M |
| March 15, 2024 | 729.96M |
| March 14, 2024 | 701.63M |
| March 13, 2024 | 730.62M |
| March 12, 2024 | 721.75M |
| March 11, 2024 | 702.69M |
| March 08, 2024 | 741.21M |
| March 07, 2024 | 746.64M |
| March 06, 2024 | 769.94M |
| March 05, 2024 | 710.63M |
| March 04, 2024 | 724.27M |
| March 01, 2024 | 655.83M |
| February 29, 2024 | 619.29M |
| February 28, 2024 | 622.14M |
| February 27, 2024 | 636.74M |
| February 26, 2024 | 619.40M |
| February 23, 2024 | 542.87M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
42.10M
Minimum
Mar 30 2023
2.304B
Maximum
Jan 07 2021
581.04M
Average
486.10M
Median
Market Cap Benchmarks
| Catalyst Pharmaceuticals Inc | 1.735B |
| Regeneron Pharmaceuticals Inc | 105.45B |
| Atossa Therapeutics Inc | 208.00M |
| ADMA Biologics Inc | 1.554B |
| Viking Therapeutics Inc | 8.487B |
Market Cap Related Metrics
| PS Ratio | 146.64 |
| Price to Book Value | 10.36 |
| Price | 54.54 |
| Earnings Yield | -41.42% |